These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
78 related articles for article (PubMed ID: 232947)
1. Growth hormone-releasing activity in extracts of bronchial carcinoid and pancreatic islet tumors associated with acromegaly. Frohman LA; Szabo M; Stachura ME; Berelowitz M Trans Assoc Am Physicians; 1979; 92():77-88. PubMed ID: 232947 [No Abstract] [Full Text] [Related]
2. Ectopic production of growth hormone-releasing factor by carcinoid and pancreatic islet tumors associated with acromegaly. Frohman LA; Szabo M Prog Clin Biol Res; 1981; 74():259-71. PubMed ID: 6275403 [No Abstract] [Full Text] [Related]
3. Acromegaly and Zollinger-Ellison syndrome secondary to an islet cell tumor: characterization and quantification of plasma and tumor human growth hormone-releasing factor. Wilson DM; Ceda GP; Bostwick DG; Webber RJ; Minkoff JR; Pont A; Hintz RL; Bensch KG; Kraemer FB; Rosenfeld RG J Clin Endocrinol Metab; 1984 Nov; 59(5):1002-5. PubMed ID: 6090497 [TBL] [Abstract][Full Text] [Related]
4. Somatotroph hyperplasia. Successful treatment of acromegaly by removal of a pancreatic islet tumor secreting a growth hormone-releasing factor. Thorner MO; Perryman RL; Cronin MJ; Rogol AD; Draznin M; Johanson A; Vale W; Horvath E; Kovacs K J Clin Invest; 1982 Nov; 70(5):965-77. PubMed ID: 6290540 [TBL] [Abstract][Full Text] [Related]
5. Partial purification and characterization of a peptide with growth hormone-releasing activity from extrapituitary tumors in patients with acromegaly. Frohman LA; Szabo M; Berelowitz M; Stachura ME J Clin Invest; 1980 Jan; 65(1):43-54. PubMed ID: 6243140 [TBL] [Abstract][Full Text] [Related]
6. Selective growth hormone and cyclic AMP stimulating activity is present in human pancreatic islet cell tumor. Cronin MJ; Rogol AD; Dabney LG; Thorner MO J Clin Endocrinol Metab; 1982 Aug; 55(2):381-3. PubMed ID: 6123522 [No Abstract] [Full Text] [Related]
7. [Immunohistochemical detection of growth hormone-releasing factor (GRF) in neuroendocrine tumors]. Gottschalk J; Rohde W Acta Histochem Suppl; 1988; 35():207-12. PubMed ID: 2843943 [TBL] [Abstract][Full Text] [Related]
8. Reduction of pituitary size by the somatostatin analogue SMS 201-995 in a patient with an islet cell tumour secreting growth hormone releasing factor. Wilson DM; Hoffman AR Acta Endocrinol (Copenh); 1986 Sep; 113(1):23-8. PubMed ID: 2876570 [TBL] [Abstract][Full Text] [Related]